Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yota Sato

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Case Reports in Oncology|May 18, 2017
Successful Treatment of Primary Cutaneous Peripheral T-Cell Lymphoma Presenting Acquired Ichthyosis with Oral Bexarotene MonotherapyKayo Tanita, Taku Fujimura, Yota Sato, et al.
Human Genome Variation|May 16, 2018
Novel <i>COL4A1</i> mutation in a fetus with early prenatal onset of schizencephalyYota Sato, Jun Shibasaki, Noriko Aida, et al.
Melanoma Research|July 14, 2020
Increased serum CCL26 level is a potential biomarker for the effectiveness of anti-PD1 antibodies in patients with advanced melanomaTaku Fujimura, Kayo Tanita, Kentaro Ohuchi, et al.
The Journal of Dermatology|March 1, 2018
HLA-DRB1*04:05 in two cases of Vogt-Koyanagi-Harada disease-like uveitis developing from an advanced melanoma patient treated by sequential administration of nivolumab and dabrafenib/trametinib therapyTaku Fujimura, Yumi Kambayashi, Kayo Tanita, et al.
The Journal of Dermatology|December 4, 2016
Successful treatment of multiple in-transit melanomas on the leg with intensity-modulated radiotherapy and immune checkpoint inhibitors: Report of two casesTaku Fujimura, Yumi Kambayashi, Sadanori Furudate, et al.
Case Reports in Oncology|February 17, 2017
Successful Treatment of Advanced Primary Cutaneous Apocrine Carcinoma on the Scrotum with Systemic Chemotherapy and Radiotherapy Followed by DenosumabSadanori Furudate, Taku Fujimura, Akira Tsukada, et al.
Experimental Dermatology|April 20, 2019
Malassezia-derived aryl hydrocarbon receptor ligands enhance the CCL20/Th17/soluble CD163 pathogenic axis in extra-mammary Paget's diseaseYota Sato, Taku Fujimura, Kayo Tanita, et al.
Life Sciences|May 15, 2012
Sortilin is required for toxic action of Aβ oligomers (AβOs): extracellular AβOs trigger apoptosis, and intraneuronal AβOs impair degradation pathwaysAyumi Takamura, Yota Sato, Daisuke Watabe, et al.
The Journal of Dermatology|March 25, 2020
Case series of cutaneous T-cell lymphomas treated with bexarotene-based therapyTaku Fujimura, Yota Sato, Kayo Tanita, et al.
Frontiers in Oncology|October 17, 2019
Bexarotene Reduces Production of CCL22 From Tumor-Associated Macrophages in Cutaneous T-Cell LymphomaKayo Tanita, Taku Fujimura, Yota Sato, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Case Reports in Oncology|May 18, 2017
Successful Treatment of Primary Cutaneous Peripheral T-Cell Lymphoma Presenting Acquired Ichthyosis with Oral Bexarotene MonotherapyKayo Tanita, Taku Fujimura, Yota Sato, et al.
Human Genome Variation|May 16, 2018
Novel <i>COL4A1</i> mutation in a fetus with early prenatal onset of schizencephalyYota Sato, Jun Shibasaki, Noriko Aida, et al.
Melanoma Research|July 14, 2020
Increased serum CCL26 level is a potential biomarker for the effectiveness of anti-PD1 antibodies in patients with advanced melanomaTaku Fujimura, Kayo Tanita, Kentaro Ohuchi, et al.
The Journal of Dermatology|March 1, 2018
HLA-DRB1*04:05 in two cases of Vogt-Koyanagi-Harada disease-like uveitis developing from an advanced melanoma patient treated by sequential administration of nivolumab and dabrafenib/trametinib therapyTaku Fujimura, Yumi Kambayashi, Kayo Tanita, et al.
The Journal of Dermatology|December 4, 2016
Successful treatment of multiple in-transit melanomas on the leg with intensity-modulated radiotherapy and immune checkpoint inhibitors: Report of two casesTaku Fujimura, Yumi Kambayashi, Sadanori Furudate, et al.
Case Reports in Oncology|February 17, 2017
Successful Treatment of Advanced Primary Cutaneous Apocrine Carcinoma on the Scrotum with Systemic Chemotherapy and Radiotherapy Followed by DenosumabSadanori Furudate, Taku Fujimura, Akira Tsukada, et al.
Experimental Dermatology|April 20, 2019
Malassezia-derived aryl hydrocarbon receptor ligands enhance the CCL20/Th17/soluble CD163 pathogenic axis in extra-mammary Paget's diseaseYota Sato, Taku Fujimura, Kayo Tanita, et al.
Life Sciences|May 15, 2012
Sortilin is required for toxic action of Aβ oligomers (AβOs): extracellular AβOs trigger apoptosis, and intraneuronal AβOs impair degradation pathwaysAyumi Takamura, Yota Sato, Daisuke Watabe, et al.
The Journal of Dermatology|March 25, 2020
Case series of cutaneous T-cell lymphomas treated with bexarotene-based therapyTaku Fujimura, Yota Sato, Kayo Tanita, et al.
Frontiers in Oncology|October 17, 2019
Bexarotene Reduces Production of CCL22 From Tumor-Associated Macrophages in Cutaneous T-Cell LymphomaKayo Tanita, Taku Fujimura, Yota Sato, et al.
Pageof 5